{
    "2021-08-15": [
        [
            {
                "time": "",
                "original_text": "太平洋金工|基金经理深度之华商基金高兵】聚焦高景气赛道，坚守优质成长股",
                "features": {
                    "keywords": [
                        "基金经理",
                        "华商基金",
                        "高兵",
                        "高景气赛道",
                        "优质成长股"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融",
                        "基金"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "【华西医药崔文亮团队】?《药明康德点评报告：业绩延续高速增长，CDMO业务和中国区实验室业务带来核心业绩增量》",
                "features": {
                    "keywords": [
                        "药明康德",
                        "CDMO业务",
                        "中国区实验室",
                        "业绩增长"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药投向标|中成药将加快集采 晶泰科技完成4亿美元D轮融资 镁信健康完成超20亿元C轮融资",
                "features": {
                    "keywords": [
                        "中成药",
                        "集采",
                        "晶泰科技",
                        "镁信健康",
                        "融资"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "中航证券给予药明康德买入评级，2021半年报点评：研发外包一体化龙头，延续强劲增长",
                "features": {
                    "keywords": [
                        "药明康德",
                        "买入评级",
                        "研发外包",
                        "强劲增长"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}